newsfilter
← Latest News
GlobeNewswire·

Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility

BUFFALO, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, ann